CD19 and B-cell chronic lymphocytic leukemia: Even though patients with relapsed/persistent CLL were more likely to retain CD19+ following CAR T-cell infusion [73], some cases exhibited escape mechanisms where antigen-negative CD19 relapse occurred [83].